134 related articles for article (PubMed ID: 31889386)
1. LDOC1 is differentially expressed in thyroid cancer and display tumor-suppressive function in papillary thyroid carcinoma.
Zhao S; Zhao Y; Wang Q; Li Z; Ma X; Wu L; Li W; Du M; Ji H; Qin G
Cell Biol Int; 2020 Apr; 44(4):985-997. PubMed ID: 31889386
[TBL] [Abstract][Full Text] [Related]
2. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
[TBL] [Abstract][Full Text] [Related]
3. Leucine Zipper Down-regulated in Cancer-1 (LDOC1) interacts with Guanine nucleotide binding protein-like 3-like (GNL3L) to modulate Nuclear Factor-kappa B (NF-κB) signaling during cell proliferation.
Thoompumkal IJ; Rehna K; Anbarasu K; Mahalingam S
Cell Cycle; 2016 Dec; 15(23):3251-3267. PubMed ID: 27764577
[TBL] [Abstract][Full Text] [Related]
4. NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymoma.
Griesinger AM; Witt DA; Grob ST; Georgio Westover SR; Donson AM; Sanford B; Mulcahy Levy JM; Wong R; Moreira DC; DeSisto JA; Balakrishnan I; Hoffman LM; Handler MH; Jones KL; Vibhakar R; Venkataraman S; Foreman NK
Neuro Oncol; 2017 Oct; 19(10):1350-1360. PubMed ID: 28510691
[TBL] [Abstract][Full Text] [Related]
5. BRAFV600E and RET/PTC Promote Proliferation and Migration of Papillary Thyroid Carcinoma Cells In Vitro by Regulating Nuclear Factor-κB.
Zhou D; Li Z; Bai X
Med Sci Monit; 2017 Nov; 23():5321-5329. PubMed ID: 29117154
[TBL] [Abstract][Full Text] [Related]
6. Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis.
Nagasaki K; Schem C; von Kaisenberg C; Biallek M; Rösel F; Jonat W; Maass N
Int J Cancer; 2003 Jul; 105(4):454-8. PubMed ID: 12712434
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of LDOC1 in human biliary epithelial cells inhibits apoptosis through NF-κB signaling.
Song Z; Dong R; Zhao R; Zheng S
J Pediatr Gastroenterol Nutr; 2013 Dec; 57(6):713-7. PubMed ID: 23942005
[TBL] [Abstract][Full Text] [Related]
8. KPNA4 regulated by miR-548b-3p promotes the malignant phenotypes of papillary thyroid cancer.
Feng L; Wang R; Yang Y; Shen X; Shi Q; Lian M; Ma H; Fang J
Life Sci; 2021 Jan; 265():118743. PubMed ID: 33188837
[TBL] [Abstract][Full Text] [Related]
9. miR-200b/c-RAP1B axis represses tumorigenesis and malignant progression of papillary thyroid carcinoma through inhibiting the NF-κB/Twist1 pathway.
Zhou B; Xu J; Chen Y; Gao S; Feng X; Lu X
Exp Cell Res; 2020 Feb; 387(2):111785. PubMed ID: 31877303
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
[TBL] [Abstract][Full Text] [Related]
11. Punicalagin induces senescent growth arrest in human papillary thyroid carcinoma BCPAP cells via NF-κB signaling pathway.
Cheng X; Yao X; Xu S; Pan J; Yu H; Bao J; Guan H; Lu R; Zhang L
Biomed Pharmacother; 2018 Jul; 103():490-498. PubMed ID: 29677534
[TBL] [Abstract][Full Text] [Related]
12. LDOC1 as Negative Prognostic Marker for Vulvar Cancer Patients.
Wanka G; Schmoeckel E; Mayr D; Fuerst S; Kuhn C; Mahner S; Knabl J; Karsten MM; Dannecker C; Heidegger HH; Vattai A; Jeschke U; Jueckstock J
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291445
[TBL] [Abstract][Full Text] [Related]
13. BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy.
Bommarito A; Richiusa P; Carissimi E; Pizzolanti G; Rodolico V; Zito G; Criscimanna A; Di Blasi F; Pitrone M; Zerilli M; Amato MC; Spinelli G; Carina V; Modica G; Latteri MA; Galluzzo A; Giordano C
Endocr Relat Cancer; 2011 Dec; 18(6):669-85. PubMed ID: 21903858
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression.
Cai X; Zhao Z; Dong J; Lv Q; Yun B; Liu J; Shen Y; Kang J; Li J
Cell Death Dis; 2019 Feb; 10(3):184. PubMed ID: 30796202
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma.
Lee CH; Wong TS; Chan JY; Lu SC; Lin P; Cheng AJ; Chen YJ; Chang JS; Hsiao SH; Leu YW; Li CI; Hsiao JR; Chang JY
J Pathol; 2013 Jul; 230(3):298-309. PubMed ID: 23362108
[TBL] [Abstract][Full Text] [Related]
16. Steroid receptor coactivator-1 interacts with NF-κB to increase VEGFC levels in human thyroid cancer.
Gao B; Guo L; Luo D; Jiang Y; Zhao J; Mao C; Xu Y
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29717026
[TBL] [Abstract][Full Text] [Related]
17. Silencing of long noncoding RNA RP11-476D10.1 enhances apoptosis and autophagy while inhibiting proliferation of papillary thyroid carcinoma cells via microRNA-138-5p-dependent inhibition of LRRK2.
Zhao Y; Zhao L; Li J; Zhong L
J Cell Physiol; 2019 Nov; 234(11):20980-20991. PubMed ID: 31102261
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
[TBL] [Abstract][Full Text] [Related]
19. The role of P62 in the development of human thyroid cancer and its possible mechanism.
Mao Y; Deng SJ; Su YJ; Diao C; Peng Y; Ma JF; Cheng RC
Cancer Genet; 2021 Aug; 256-257():5-16. PubMed ID: 33780725
[TBL] [Abstract][Full Text] [Related]
20. JAZF1 Suppresses Papillary Thyroid Carcinoma Cell Proliferation and Facilitates Apoptosis via Regulating TAK1/NF-κB Pathways.
Huang L; Cai Y; Luo Y; Xiong D; Hou Z; Lv J; Zeng F; Yang Y; Cheng X
Onco Targets Ther; 2019; 12():10501-10514. PubMed ID: 31819531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
